Anavex Life Sciences Corp (AVXL)

[RedShoulder]

Mayo, it appears that the 'holiday' break showing that the decline after making gains in the trial; then picked right back up once being put back on Blarcamesine, gave unsolicited but highly useful and positive data.

Besides confirming that the drug does work, it show that the patients will be on the drug until death; it's not a one shot revenue. That means a lifetime of reoccurring revenues until death do them part.